解释全血细胞计数参数在健康和疾病

E. O.
{"title":"解释全血细胞计数参数在健康和疾病","authors":"E. O.","doi":"10.23880/hij-16000180","DOIUrl":null,"url":null,"abstract":"The full blood count (FBC) or Complete Blood Count (CBC) is one of the most frequently requested haematological investigation performed in patients. It has the potential, when interpreted carefully and in relation to the clinical history can potentially yield very useful clinical information that assist in diagnosis and management of patients by clinicians. It usually comprises 13–19 parameters. The aim of this review was to highlight the evidenced based interpretation of full blood count parameters in health and disease. PubMed, Google Scholar, Science Direct and African Journals Online search was performed in January 2020 and studies on the components of a normal full blood count in health and several disease states was included in the review. Search keywords included full blood count and its clinically significance. FBC is a readily available test whose clinical utility is far reaching and can potentially monitor effect of drug treatment, pre-operative intervention and in the diagnosis of diseases such as anaemia, cancer, clotting issues, infection and immune system disorder. The parameters included in a normal FBC are sometimes under-utilized as most clinicians and nurses rely more on three of the components (HB, WBC and platelet count). FBC determination using either the 3 of 5-part differential haematology analyzer should be based on SOP using certified reagents, validated equipment and quality controlled (IQC and EQA) testing in a Good Laboratory Practice compliant laboratory. All clinically significant analyzer generated flags must be investigated. All results must be technically and clinically validated. Laboratories must identify findings and flags that should warrant the examination of a peripheral blood film as well as results that need to be communicated promptly to the requesting clinician to facilitate the need for immediate remedial action and effective management of patients. It is vital that result is not reviewed in isolation but holistically looking at trends over time and taking into consideration known diagnosis.","PeriodicalId":245976,"journal":{"name":"Haematology International Journal","volume":"335 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Interpretation of Full Blood Count Parameters in Health and Disease\",\"authors\":\"E. O.\",\"doi\":\"10.23880/hij-16000180\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The full blood count (FBC) or Complete Blood Count (CBC) is one of the most frequently requested haematological investigation performed in patients. It has the potential, when interpreted carefully and in relation to the clinical history can potentially yield very useful clinical information that assist in diagnosis and management of patients by clinicians. It usually comprises 13–19 parameters. The aim of this review was to highlight the evidenced based interpretation of full blood count parameters in health and disease. PubMed, Google Scholar, Science Direct and African Journals Online search was performed in January 2020 and studies on the components of a normal full blood count in health and several disease states was included in the review. Search keywords included full blood count and its clinically significance. FBC is a readily available test whose clinical utility is far reaching and can potentially monitor effect of drug treatment, pre-operative intervention and in the diagnosis of diseases such as anaemia, cancer, clotting issues, infection and immune system disorder. The parameters included in a normal FBC are sometimes under-utilized as most clinicians and nurses rely more on three of the components (HB, WBC and platelet count). FBC determination using either the 3 of 5-part differential haematology analyzer should be based on SOP using certified reagents, validated equipment and quality controlled (IQC and EQA) testing in a Good Laboratory Practice compliant laboratory. All clinically significant analyzer generated flags must be investigated. All results must be technically and clinically validated. Laboratories must identify findings and flags that should warrant the examination of a peripheral blood film as well as results that need to be communicated promptly to the requesting clinician to facilitate the need for immediate remedial action and effective management of patients. It is vital that result is not reviewed in isolation but holistically looking at trends over time and taking into consideration known diagnosis.\",\"PeriodicalId\":245976,\"journal\":{\"name\":\"Haematology International Journal\",\"volume\":\"335 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Haematology International Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23880/hij-16000180\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Haematology International Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23880/hij-16000180","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

全血细胞计数(FBC)或全血细胞计数(CBC)是患者最常要求的血液学调查之一。当仔细解释并与临床病史联系起来时,它有可能产生非常有用的临床信息,帮助临床医生诊断和管理患者。通常由13-19个参数组成。本综述的目的是强调基于证据的全血细胞计数参数在健康和疾病中的解释。PubMed、Google Scholar、Science Direct和African Journals Online于2020年1月进行了搜索,对健康和几种疾病状态下正常全血细胞计数组成部分的研究被纳入了该综述。搜索关键词包括全血细胞计数及其临床意义。FBC是一种易于获得的测试,其临床用途非常广泛,可以潜在地监测药物治疗的效果,术前干预,以及贫血,癌症,凝血问题,感染和免疫系统紊乱等疾病的诊断。由于大多数临床医生和护士更多地依赖于其中三个组成部分(血红蛋白、白细胞和血小板计数),因此正常红细胞计数中包含的参数有时未得到充分利用。使用3部或5部差分血液学分析仪进行FBC测定应基于SOP,使用经过认证的试剂、经过验证的设备,并在符合良好实验室规范的实验室进行质量控制(IQC和EQA)测试。必须调查所有具有临床意义的分析仪生成的标记。所有结果必须经过技术和临床验证。实验室必须识别外周血膜检查的发现和标志,以及需要及时与请求临床医生沟通的结果,以促进立即采取补救措施和有效管理患者的需要。至关重要的是,不应孤立地审查结果,而应全面观察长期趋势,并考虑到已知的诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Interpretation of Full Blood Count Parameters in Health and Disease
The full blood count (FBC) or Complete Blood Count (CBC) is one of the most frequently requested haematological investigation performed in patients. It has the potential, when interpreted carefully and in relation to the clinical history can potentially yield very useful clinical information that assist in diagnosis and management of patients by clinicians. It usually comprises 13–19 parameters. The aim of this review was to highlight the evidenced based interpretation of full blood count parameters in health and disease. PubMed, Google Scholar, Science Direct and African Journals Online search was performed in January 2020 and studies on the components of a normal full blood count in health and several disease states was included in the review. Search keywords included full blood count and its clinically significance. FBC is a readily available test whose clinical utility is far reaching and can potentially monitor effect of drug treatment, pre-operative intervention and in the diagnosis of diseases such as anaemia, cancer, clotting issues, infection and immune system disorder. The parameters included in a normal FBC are sometimes under-utilized as most clinicians and nurses rely more on three of the components (HB, WBC and platelet count). FBC determination using either the 3 of 5-part differential haematology analyzer should be based on SOP using certified reagents, validated equipment and quality controlled (IQC and EQA) testing in a Good Laboratory Practice compliant laboratory. All clinically significant analyzer generated flags must be investigated. All results must be technically and clinically validated. Laboratories must identify findings and flags that should warrant the examination of a peripheral blood film as well as results that need to be communicated promptly to the requesting clinician to facilitate the need for immediate remedial action and effective management of patients. It is vital that result is not reviewed in isolation but holistically looking at trends over time and taking into consideration known diagnosis.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Sickle Cell Disease Control Prospects the Emerging Necessities Due to Impactful COVID-19 Pandemic in Sub Saharan Africa The Alfresco Aqueducts- Extrahepatic Cholangiocarcinoma Therapy with Plasma Growth Factors: Controversies of Key at Cellular Therapy Hemorrhage in the Setting of Acute Severe Refractory Immune Thrombocytopenic Purpura: A Case Report Changes in Loc285758 Expression in Response to Cytarabine- Based Treatment in Patients with Acute Myeloid Leukemia
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1